Search for: "Sherman LePage" Results 1 - 13 of 13
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Dec 2011, 5:36 am by Barry Barnett
Circuit to reject what it (C&D) deemed an extreme reading of Sherman Act section 2 -- the Third Circuit's en banc decision in LePage's Inc. v. 3M, 324 F.3d 141 (3d Cir. 2003) (en banc). [read post]
15 Dec 2011, 3:47 pm
According to the court, an inquiry into the bundling of rebates on condoms and other types of products with the purpose of sustaining market power in the market for condoms is arguably within the condemnation of the Sherman Act as the Third Circuit construed it in LePage’s. [read post]
19 Dec 2020, 8:11 pm by Bona Law PC
The Discount-Attribution Test for Bundled Discounts In PeaceHealth, the Ninth Circuit overturned a jury verdict against defendant for violating Section 2 of the Sherman Act by bundling (among other conduct). [read post]
27 Jan 2007, 9:18 pm
Congress should not legislatively amend Section 2 of the Sherman Act. [read post]
8 Jun 2011, 3:20 pm by Barry Barnett
A jury agreed and found Brunswick guilty of violating the Sherman Act, awarding more than $140 million (after trebling). [read post]
2 Sep 2016, 6:50 am by Jim Sedor
Paul LePage told reporters he will not be stepping down and will seek spiritual guidance. [read post]
1 May 2008, 4:35 am
Discount Attribution Approach - The Peacehealth court examined whether a bundled discount constituted attempted monopolization under the Sherman Act. [read post]
22 Feb 2009, 9:10 pm
  For example, does anybody really believe that LePage’s did not result in some chilling on the margin of pro-competitive bundled discount schemes? [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]